Advanced search
1 file | 214.40 KB Add to list

Scheduled maintenance: Publication downloads temporarily unavailable.

Due to maintenance publication downloads will not be available on:

  • Wednesday, March 27, 17:00 – 21:00
  • Thursday, March 28, 17:00 – 21:00

Exports of lists, FWO and BOF information will remain available.

For any questions, please contact biblio@ugent.be. Apologies for any inconveniences, and thank you for your understanding.

The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice

(2007) ANNALS OF THE RHEUMATIC DISEASES. 66(8). p.1072-1077
Author
Organization
Keywords
PLACEBO-CONTROLLED TRIAL, ASAS CONSENSUS STATEMENT, DOUBLE-BLIND, DISEASE-ACTIVITY, AGENTS, INDEX, BATH, SPONDYLARTHROPATHY, MULTICENTER, INFLIXIMAB

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 214.40 KB

Citation

Please use this url to cite or link to this publication:

MLA
Vander Cruyssen, Bert, et al. “The Epidemiology of Ankylosing Spondylitis and the Commencement of Anti-TNF Therapy in Daily Rheumatology Practice.” ANNALS OF THE RHEUMATIC DISEASES, vol. 66, no. 8, 2007, pp. 1072–77, doi:10.1136/ard.2006.064543.
APA
Vander Cruyssen, B., Ribbens, C., Boonen, A., Mielants, H., De Vlam, K., Lenaerts, J., … Vastesaeger, N. (2007). The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice. ANNALS OF THE RHEUMATIC DISEASES, 66(8), 1072–1077. https://doi.org/10.1136/ard.2006.064543
Chicago author-date
Vander Cruyssen, Bert, Clio Ribbens, Annelies Boonen, Herman Mielants, Kurt De Vlam, Jan Lenaerts, Serge Steinfeld, Filip Van den Bosch, Lode Dewulf, and Nathan Vastesaeger. 2007. “The Epidemiology of Ankylosing Spondylitis and the Commencement of Anti-TNF Therapy in Daily Rheumatology Practice.” ANNALS OF THE RHEUMATIC DISEASES 66 (8): 1072–77. https://doi.org/10.1136/ard.2006.064543.
Chicago author-date (all authors)
Vander Cruyssen, Bert, Clio Ribbens, Annelies Boonen, Herman Mielants, Kurt De Vlam, Jan Lenaerts, Serge Steinfeld, Filip Van den Bosch, Lode Dewulf, and Nathan Vastesaeger. 2007. “The Epidemiology of Ankylosing Spondylitis and the Commencement of Anti-TNF Therapy in Daily Rheumatology Practice.” ANNALS OF THE RHEUMATIC DISEASES 66 (8): 1072–1077. doi:10.1136/ard.2006.064543.
Vancouver
1.
Vander Cruyssen B, Ribbens C, Boonen A, Mielants H, De Vlam K, Lenaerts J, et al. The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice. ANNALS OF THE RHEUMATIC DISEASES. 2007;66(8):1072–7.
IEEE
[1]
B. Vander Cruyssen et al., “The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice,” ANNALS OF THE RHEUMATIC DISEASES, vol. 66, no. 8, pp. 1072–1077, 2007.
@article{388415,
  author       = {{Vander Cruyssen, Bert and Ribbens, Clio and Boonen, Annelies and Mielants, Herman and De Vlam, Kurt and Lenaerts, Jan and Steinfeld, Serge and Van den Bosch, Filip and Dewulf, Lode and Vastesaeger, Nathan}},
  issn         = {{0003-4967}},
  journal      = {{ANNALS OF THE RHEUMATIC DISEASES}},
  keywords     = {{PLACEBO-CONTROLLED TRIAL,ASAS CONSENSUS STATEMENT,DOUBLE-BLIND,DISEASE-ACTIVITY,AGENTS,INDEX,BATH,SPONDYLARTHROPATHY,MULTICENTER,INFLIXIMAB}},
  language     = {{eng}},
  number       = {{8}},
  pages        = {{1072--1077}},
  title        = {{The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice}},
  url          = {{http://doi.org/10.1136/ard.2006.064543}},
  volume       = {{66}},
  year         = {{2007}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: